Monoclonal antibody CC49 I-131Alternative Names: I-131 monoclonal antibody CC49; Monoclonal antibody I-131 CC49
Latest Information Update: 15 Aug 2007
At a glance
- Originator Corixa Corporation
- Class Antineoplastics; Immunotherapies; Monoclonal antibodies; Radiopharmaceuticals
- Mechanism of Action Ionising radiation emitters
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
On Fast track
Fast track status is assigned by the US FDA so therapies with the potential to address unmet needs can move faster through development.
- New Molecular Entity No
Highest Development Phases
- Discontinued Cancer
Most Recent Events
- 14 Mar 2001 Preclinical development for Cancer in USA (Parenteral)